Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review
- 1 March 2017
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 389 (10073) , 1035-1042
Abstract
No abstract availableKeywords
Funding Information
- National Heart Foundation of Australia (grant number 100227)
This publication has 27 references indexed in Scilit:
- Randomized Polypill Crossover Trial in People Aged 50 and OverPLOS ONE, 2012
- Combination therapy as initial treatment for newly diagnosed hypertensionAmerican Heart Journal, 2011
- Effects of Intensive Blood-Pressure Control in Type 2 Diabetes MellitusNew England Journal of Medicine, 2010
- Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studiesBMJ, 2009
- A Simplified Approach to the Treatment of Uncomplicated HypertensionHypertension, 2009
- Low-Dose Quadruple Antihypertensive CombinationHypertension, 2007
- Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trialsBMJ, 2003
- The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: The RENAAL StudyKidney International, 2003
- Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 DiabetesNew England Journal of Medicine, 2001
- Predictors of the progression of renal disease in the Modification of Diet in Renal Disease StudyKidney International, 1997